Many cannabis stocks have experienced significant growth over the past six months. For instance, shares of Tilray Brands ...

Trump’s order reclassifies marijuana as a Schedule III drug from Schedule I, but doesn’t permit legalized recreational sales. Other Schedule I substances include highly addictive drugs with no ...

In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related to rescheduling marijuana as a less-dangerous drug.

Recent regulatory developments have improved the landscape of the cannabis industry in the U.S. Canopy Growth and Aurora ...

Marijuana's potential move to Schedule III could reshape cannabis economics, putting CRON, VFF and TLRY in focus for 2026 ...

Federal rescheduling efforts, coupled with improved corporate balance sheets, may finally unlock long-awaited profitability for cannabis-sector leaders.

Cannabis companies experienced a remarkable Thursday as investors responded enthusiastically to reports that President Donald Trump plans to sign an executive order addressing federal marijuana ...

Cannabis stocks jump as Trump signs executive order to reclassify marijuana, easing federal rules and boosting investment potential.

I recently saw a social media post which stood out to me. This post was a long-term chart going back about 50 years, ...